🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Larimar Therapeutics, Inc.

LRMR Healthcare
$4.25 +$0.19 (4.68%)
Market Cap: $443.63 M
Gurus Holding
3
Popularity Rank
#2966
% of Shares Held
2.69%
Net Activity (Q2 2026)
+$547,607.4

Guru Ownership Trend

Guru Analysis for Larimar Therapeutics, Inc. (LRMR)

Larimar Therapeutics, Inc. (LRMR), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $11.92 M.

Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $547,607.4 net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 190.1%. Conversely, Steven Cohen reduced exposure by 87.1%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$4.74 M
Total Buy Value
New Buys 0
Additions 1
-$4.19 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
3
Net Buyers
1

FAQs for Larimar Therapeutics, Inc. (LRMR)

Major holders include Cliff Asness ($7.23 M), Renaissance Technologies (RenTech) ($907,201), Steven Cohen ($411,158). According to the latest reported data, 3 tracked investment managers collectively hold approximately 2.8 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $547,607.4, with 1 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited LRMR. The total reported sell value was $4.19 M.

Yes, 0 managers opened new positions in LRMR, and 1 increased their existing holdings. The total reported buy value was $4.74 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 190.1% 2,371,414 $7.23 M Q2 2026
0.00% Reduce -59.8% 297,443 $907,201 Q2 2026
0.00% Reduce -87.1% 134,806 $411,158 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form